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OBJECTIVES We sought to derive gender-specific cardiovascular magnetic resonance (CMR) reference
values for normative left ventricular (LV) anatomy and function in a healthy adult population
of clinically relevant age.
BACKGROUND Cardiovascular magnetic resonance imaging is increasingly applied in the clinical setting, but
age-relevant, gender-specific normative values are currently unavailable.
METHODS A representative sample of 318 Framingham Heart Study (FHS) Offspring participants free
of clinically overt cardiovascular disease underwent CMR examination to determine LV
end-diastolic and end-systolic volume (EDV and ESV, respectively), mass, ejection fraction
(EF) and linear dimensions (wall thickness, cavity length). Subjects with a clinical history of
hypertension or those with a systolic blood pressure 140 mm Hg or diastolic pressure 90
mm Hg at any FHS cycle examination were excluded, leaving 142 subjects (63 men, 79
women; age 57  9 years).
RESULTS All volumetric (EDV, ESV, mass) and unidimensional measures were significantly greater
(p  0.001) in men than in women and remained greater (p  0.02) after adjustment for
subject height. Volumetric measures were greater (p  0.001) in men than in women after
adjustment for body surface area (BSA), but there were increased linear dimensions in women
after adjustment for BSA. In particular, end-diastolic dimension indexed to BSA was greater
in women (p  0.001) than in men. There were no gender differences in global LVEF
(men  0.69; women  0.70).
CONCLUSIONS Cardiovascular magnetic resonance measures of LV volumes, mass and linear dimensions
differ significantly according to gender and body size. This study provides gender-specific
normal CMR reference values, uniquely derived from a population-based sample of persons
free of cardiovascular disease and clinical hypertension. These data may serve as a reference
to identify LV pathology in the adult population. (J Am Coll Cardiol 2002;39:1055–60)
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Normative reference values for left ventricular (LV) anat-
omy and function are important for accurate identification
of disease, risk stratification and selection of therapy (1–4).
Cardiovascular magnetic resonance (CMR) imaging allows
accurate, unbiased determination of LV anatomy and func-
tion without geometric assumptions regarding ventricular
shape (5). It also provides high spatial and temporal reso-
lution and does not expose patients to potentially harmful
ionizing radiation, making it ideal for serial assessments.
Reference standards for LV anatomy and function derived
using other invasive or noninvasive imaging modalities
may not be appropriate for values measured from CMR data
(6,7). Furthermore, because CMR is increasingly used for
clinical assessment of LV size, function and mass, specific
CMR-derived reference values are desirable. Age-
appropriate reference standards are particularly important
for identification of disease; however, prior reports of CMR
reference values typically have employed young adult vol-
unteers (8,9) or have been derived from relatively small
sample sizes. Another factor in establishing normal refer-
ence values is gender differences in LV structure, which
becomes particularly relevant with increasing age (10,11).
Thus, we sought to determine CMR reference values for
LV size, function and mass in a large, longitudinally
followed, population-based cohort of middle-aged and older
men and women free of clinically overt cardiovascular
disease. The closely monitored Offspring cohort of the
Framingham Heart Study (FHS), initiated in 1971, repre-
sents an appropriate sample in which cardiovascular disease,
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hypertension and valvular heart disease can be excluded,
making it uniquely suitable for determination of CMR
reference values in the adult population.
METHODS
Subjects. The study design and selection criteria for the
FHS Offspring study have been described previously (12).
Adult participants in the FHS Offspring cohort who live in
Massachusetts or a contiguous state were recruited to
undergo CMR imaging using a random sampling strategy
to recruit from strata of gender, decade age and quintile of
Framingham coronary disease risk score (13). Using this
sampling strategy, a representative sample of 318 subjects
was recruited. Potential subjects were excluded if there were
contraindications to CMR imaging, including pacemaker,
implanted cardiodefibrillator, metallic intraocular or intra-
cranial clips, history of foreign ocular bodies or claustropho-
bia. Participants with known chronic atrial fibrillation were
also excluded. A total of 318 subjects underwent CMR
imaging; all were free of clinically apparent cardiovascular
disease, including angina and myocardial infarction. For the
purpose of establishing reference values, we subsequently
excluded subjects with a clinical history of hypertension,
those taking an antihypertensive medication during any
FHS cycle examination visit, or those with a resting systolic
blood pressure 140 mm Hg or diastolic blood pressure
90 mm Hg (14) during any FHS examination. The study
was approved by human study committees of both the
Boston University School of Medicine and Beth Israel
Deaconess Medical Center. Written informed consent was
obtained from all participants.
Imaging. Cardiovascular magnetic resonance imaging was
performed with subjects positioned supine in a 1.5-T
scanner using a 5-element cardiac array coil for radiofre-
quency signal detection (Gyroscan ACS/NT, Philips Med-
ical Systems, Best, The Netherlands). Following scout
images to determine the position and orientation of the
heart within the thorax, images were acquired using a
prospective, electrocardiogram (ECG)-triggered K-space
segmented hybrid gradient-echo echo-planar breath-hold
cine sequence (15). A stack of 10-mm thick contiguous
slices encompassing the left ventricle from base to apex in
the cardiac short-axis orientation was acquired during a
series of end-tidal breath-holds. Imaging parameters in-
cluded the following: repetition time  R-R interval, echo
time  9 ms, flip angle  30°, effective temporal resolution
of 39 ms. In-plane spatial resolution was 1.25  2.0 mm2.
Image analysis. All image analysis was performed by an
observer blinded to all clinical history (including age and
gender) using a commercially available EasyScil workstation
(Philips Medical Systems). Endocardial LV borders were
manually traced at end-diastole (the first image in the
ECG-gated cine dataset) and at end-systole (the cardiac
phase with minimal cross-sectional area) (Fig. 1). In the
tracing convention used, the papillary muscles were included
as part of LV cavity volume. Left ventricular end-diastolic
volume (EDV) and end-systolic volume (ESV) were deter-
mined using a summation of disks (“Simpson’s Rule”)
method. Ejection fraction (EF) was computed as EF 
(EDV  ESV)/EDV. Left ventricular epicardial borders
were also traced on the end-diastolic images with LV mass
computed as the end-diastolic myocardial volume (i.e.,
epicardial  endocardial volumes) multiplied by myocardial
density (1.05 g/ml). Intraobserver and interobserver repro-
ducibility for LV volumetric measures by our group have
been previously reported (16). In addition to volumetric
measurements, one-dimensional measurements of LV end-
diastolic dimension (EDD), posterior wall thickness (PWT)
and anterior interventricular septum thickness (IVS) were
measured from an end-diastolic short-axis slice immediately
basal to the tips of the papillary muscles. Finally, end-
diastolic LV long-axis lengths, from the apical endocardial
border to the mitral valve plane, were measured from both
the two-chamber and four-chamber data sets.
Statistical analysis. Descriptive anthropomorphic charac-
teristics are presented by gender, with continuous variables
summarized as mean 1 SD. Left ventricular volume, mass
and linear dimensions are presented by gender as mean
values and 95th percentile upper limits; between-gender
differences were assessed using Student t tests. Whole-group
and gender-specific regression analyses were performed to
investigate the relations between LV parameters and height
and calculated body surface area (BSA) (17), which were
summarized using Pearson correlation. Height and weight
were measured during subjects’ contemporaneous FHS exam-
inations. Further analyses of LV parameters were conducted
after adjustment for subject height (m) and BSA (m2).
RESULTS
Of the 318 FHS subjects who underwent CMR imaging,
176 were excluded for hypertension, leaving 142 subjects
(63 men, 79 women) for determination of normative data.
Clinical characteristics for this group are presented by
gender in Table 1. Image quality was deemed not adequate
for analysis in 5 (3.5%) of 142 subjects; unacceptable image
quality was due primarily to subject difficulties in perform-
Abbreviations and Acronyms
BMI  body mass index
BSA  body surface area
CMR  cardiovascular magnetic resonance
ECG  electrocardiogram
EDD  end-diastolic dimension
EDV  end-diastolic volume
EF  ejection fraction
ESV  end-systolic volume
FHS  Framingham Heart Study
IVS  interventricular septum thickness
LV  left ventricular
PWT  posterior wall thickness
1056 Salton et al. JACC Vol. 39, No. 6, 2002
Gender Differences in Normal LV Anatomy by Cardiac MR March 20, 2002:1055–60
ing 10- to 15-second end-tidal breath-holds. Mean values
and 95th percentile upper limits for LV mass, EDV, ESV,
EF and linear dimensions based on 137 subjects are pre-
sented by gender in Table 2. The 5th percentile (lower)
limits for EF were 0.59 for men and 0.60 for women.
Except for EF, all unadjusted LV parameters were signifi-
cantly greater in men than in women (p  0.001).
In the pooled group of men and women, LV EDV, ESV,
mass and linear dimensions each correlated significantly
with height (r  0.38 to 0.69, p  0.001 for all) and BSA
(r  0.41 to 0.78, p  0.001 for all), indicating that
adjustment for body size is warranted. Apart from EDD,
significant gender differences persisted after adjustment for
subject height (Table 2). After adjustment for BSA (Table
2), volumetric variables (LV mass, EDV, ESV) remained
significantly greater (p 0.001) in men than in women, but
EDD and two-chamber long-axis length were significantly
greater in women than in men (p  0.001), with a trend
(p  0.09) toward greater PWT, IVS and four-chamber
length in women.
DISCUSSION
In this sample of healthy subjects from the prospective FHS
Offspring cohort who were free of hypertension and symp-
tomatic cardiovascular disease, we define normative CMR
reference values for LV anatomy and global systolic func-
tion. There is increasing interest in and application of CMR
Figure 1. Representative double-oblique short-axis images at the basal (left column), mid (middle column) and apical (right column) left ventricular levels,
demonstrating the delineation of endocardial and epicardial borders.
Table 1. Descriptive Characteristics of Subjects
Variable Mean SD Minimum Maximum
Men (n  63)
Age (yr) 56.7 9.1 38 72
SBP (mm Hg) 116.3 12.0 92 139
DBP (mm Hg) 72.5 7.7 56 88
Height (m) 1.75 0.06 1.63 1.92
Weight (kg) 85.1 15.8 54.4 130.6
BMI (kg/m2) 27.8 4.91 19.7 43.2
BSA (m2) 2.00 0.18 1.60 2.47
Women (n  79)
Age (yr) 57.7 9.5 36 78
SBP (mm Hg) 115.2 11.9 90 137
DBP (mm Hg) 70.6 8.3 53 86
Height (m) 1.62 0.06 1.48 1.77
Weight (kg) 65.7 14.4 42.6 123.4
BMI (kg/m2) 25.0 5.0 18.4 46.0
BSA (m2) 1.69 0.18 1.35 2.24
BMI  body mass index, BSA  body surface area, DBP  diastolic blood pressure,
SBP  systolic blood pressure.
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imaging for clinical evaluation and epidemiologic study of
LV structure and function. Thus, CMR-specific reference
standards for LV anatomy and systolic function are needed
for identification of disease, risk stratification and monitor-
ing of the effects of therapy. The principal challenges to
development of appropriate, gender-specific reference stan-
dards are the confounding influence of cardiovascular dis-
ease, particularly in older adults, or the assumption that data
derived from apparently healthy young volunteers can be
extrapolated to older adult populations with known or
suspected disease. The FHS Offspring cohort consists of
middle-aged and older men and women who have under-
gone periodic medical examinations for more than 25 years.
Thus, the study sample is a uniquely well-characterized
cohort, from which a healthy, population-based reference
sample allows for determination of gender-specific norma-
tive CMR reference values.
Gender differences and impact of adjustment for height
and BSA. As has been described for both echocardio-
graphic and smaller CMR series, absolute LV mass, EDV,
ESV and linear dimensions were significantly greater in
men than in women. This emphasizes the need for gender-
specific reference values, as use of gender-indifferent thresh-
old values for LV hypertrophy or chamber dilation would
lead to reduced sensitivity for women and reduced specific-
ity for men. Data from the present study, as well as previous
work by others and us, indicate that LV mass, volume and
linear dimensions are significantly correlated with body
Table 2. Means and 95% Upper Limits for Raw, Height-Adjusted, and BSA-Adjusted
LV Variables
Variables
Raw
p Value*
Men Women
Mean
95% Upper
Limit Mean
95% Upper
Limit
LV mass (g) 155.1 201.4 103.0 134.0 0.0001
LV EDV (ml) 114.9 169.0 84.4 116.5 0.0001
LV ESV (ml) 36.3 65.0 25.1 40.9 0.0001
PWT (mm) 9.9 11.2 8.7 9.8 0.0001
IVS (mm) 10.1 11.7 8.9 10.1 0.0001
EDD (mm) 50.2 58.5 45.6 51.1 0.0001
2-ChL (mm) 82.3 93.8 73.2 83.7 0.0001
4-ChL (mm) 81.9 93.0 71.7 81.5 0.0001
LV EF 0.69 0.77 0.70 0.79 0.1019
Variables
Raw/Height
p Value*
Men Women
Mean
95% Upper
Limit Mean
95% Upper
Limit
LV mass (g/m) 88.6 114.0 63.6 81.9 0.0001
LV EDV (ml/m) 65.6 93.6 52.1 70.3 0.0001
LV ESV (ml/m) 20.7 35.5 15.5 24.5 0.0001
PWT (mm/m) 5.6 6.5 5.4 6.1 0.0013
IVS (mm/m) 5.8 6.9 5.5 6.4 0.0134
EDD (mm/m) 28.7 33.1 28.2 31.8 0.1616
2-ChL (mm/m) 47.1 52.1 45.1 49.8 0.0009
4-ChL (mm/m) 46.9 53.0 44.3 49.3 0.0001
Variables
Raw/BSA
p Value*
Men Women
Mean
95% Upper
Limit Mean
95% Upper
Limit
LV mass (g/m2) 77.9 95.0 60.8 74.7 0.0001
LV EDV (ml/m2) 57.6 79.5 49.8 65.5 0.0001
LV ESV (ml/m2) 18.1 30.8 14.8 24.0 0.0001
PWT (mm/m2) 5.0 6.0 5.2 6.3 0.0523
IVS (mm/m2) 5.1 6.2 5.3 6.4 0.0564
EDD (mm/m2) 25.3 29.7 27.1 31.8 0.0004
2-ChL (mm/m2) 41.3 46.8 43.5 48.4 0.0005
4-ChL (mm/m2) 41.5 47.7 42.7 47.8 0.0867
*p Values are from the test of difference in means between genders for each of the LV variables.
ChL  chamber length; EDD  end diastolic dimension; EDV  end-diastolic volume; EF  ejection fraction; ESV 
end-systolic volume; IVS  inter-ventricular septum thickness; LV  left ventricle; PWT  posterior wall thickness
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habitus, so that adjustment is warranted to account for
differences in body size (8,9,18,19). As in these prior
reports, we reported adjustment with respect to body height
and to BSA; these measures are commonly used to index
cardiac data with other imaging modalities. Height is simple
to determine and is strongly associated with lean body mass
(19), may best reflect metabolic demands on the heart (20),
and does not make allowance for obesity. Direct measure-
ment of lean body mass is difficult to acquire in the clinical
setting. Obesity is associated with LV hypertrophy (21,22);
indexing LV measurements by weight thus might fail to
detect pathologic levels of LV mass and, accordingly, was
not developed in this report. Body surface area makes partial
allowance for obesity, as weight is used in conjunction with
height to determine BSA. In the present study, gender
differences persisted after adjustment for height, except in
the case of EDD, which was similar in men and women.
Adjustment for BSA resulted in a tendency toward “cross-
over” with greater linear dimensions in women compared
with men. The physiologic or prognostic implications of
this gender-differential effect of adjustment for BSA are
unknown and await further study with a larger cohort.
Comparison with previous CMR studies. Several inves-
tigators have reported normal CMR indexes for cardiac
anatomy and function based on findings from relatively
young cohorts. In the two largest series to date, Lorenz et al.
(8) reported normal LV CMR values in 75 healthy subjects
(28 women, 47 men; age 28 9 years), and Marcus et al. (9)
described LV parameters in 61 healthy young adults (32
men, 29 women; mean age 22  2 years). Consistent with
the findings of the present study, both investigators reported
greater LV volume and mass in men, before and after
adjustment for height and BSA. Compared with our results,
however, both Lorenz and Marcus reported greater EDV
values, regardless of gender or adjustment method. This
may be due in part to the younger age of their participants,
or population differences in habitual physical activity. With
respect to LV mass, mean values in the Marcus study were
lower than corresponding values in our study. This may
reflect differences in body habitus, as well as age; the greatest
proportional difference was observed after adjustment for
height, which does not make allowance for obesity or
overweight. Subjects in the Marcus study were substantially
taller (men: 1.83  0.07 m, women: 1.71  0.07 m) and
leaner (men: body mass index [BMI]  23.1  2.7 kg/m2;
women: BMI  21.6  2.5 kg/m2) than participants in our
study (Table 1). The above studies should be viewed as
complementary to the present study, as the subjects were
principally drawn from a young-adult age group not repre-
sented in this report.
Comparison with echocardiographic studies. Although
two-dimensional (2D) and three-dimensional (3D) echo-
cardiography are available for measurement of LV anatomy
and systolic function, M-mode echocardiography, because
of its ease of acquisition and measurement, remains the
most widely used method for determination of LV dimen-
sion and mass, both in clinical practice and in many research
studies. Cardiovascular magnetic resonance imaging-
derived LV EDD and wall thickness in the present study
were similar to corresponding M-mode derived values
obtained from 914 clinically healthy FHS subjects in a
separate study (23). In the present study, however, gender-
specific values for normal CMR LV mass are lower than
previously reported M-mode-derived values obtained from
864 healthy adults drawn from the same FHS Offspring
cohort (24) and likely reflect differences between CMR and
M-mode echocardiographic derived volumes and mass. In
support of this hypothesis, another study of 111 healthy,
normotensive adults (25) found that M-mode echocardio-
graphically derived mass was greater than volumetric CMR
mass. In a third series of healthy normotensive subjects (19),
M-mode values for LV mass are more comparable to our
data, although mean M-mode mass still exceeded the CMR
mass values of the present study. Notably, the proposed
upper 95th percentile “limits of normal” for LV mass in each
of the echocardiographic studies (men: 259 g, 143 g/m,
261 g; women: 166 g, 123 g/m, 191 g, respectively, for the
three studies) are substantially greater than the correspond-
ing upper 95th percentile values in the present CMR study
(Table 2). Although not widely available, 3D echocardiog-
raphy yields excellent agreement with CMR imaging for LV
volume (16) and mass. Analogous to our findings, M-mode
derived mass is significantly greater than 3D echo mass in
the same subjects (26).
Rationale for CMR imaging. Cardiovascular magnetic
resonance imaging is highly reproducible (16,27) and may
be particularly advantageous in traditionally difficult-to-
image patients with obese body habitus or pulmonary
disease, as CMR is not dependent on adequate acoustic
windows for imaging (28) and does not suffer from atten-
uation artifacts associated with radionuclide imaging. In the
present study, adequate or better quality images suitable for
analysis were obtained in 137 (96.5%) of 142 subjects. Use
of recently developed non-breath-hold real-time CMR
techniques (29,30) may have allowed acquisition of analyz-
able images in the remaining five subjects, but we did not
pursue this option, in the interest of methodological con-
sistency. In the context of clinical studies, use of CMR
imaging may minimize selection bias associated with echo-
cardiography (31), which disproportionally excludes obese
and elderly subjects (10). Furthermore, the excellent repro-
ducibility of CMR may allow dramatic reductions in sample
size needed to observe response to experimental treatments
(7,27).
Study limitations. This study was not designed or powered
to address possible age-related changes in LV parameters.
However, the FHS study sample represents a clinically
relevant adult population, about which CMR normative
data were previously unknown. This closely followed cohort
allowed us to more carefully screen for hypertension and
other potential confounders. The FHS sample was over-
whelmingly caucasian. The results of the present study may
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not be generalized to non-caucasian populations. Finally, we
did not control for physical activity, which is known to
increase both EDV and LV mass, although such changes
are generally considered “physiologic” and are not believed
to be indicative of disease (32).
Conclusions. Cardiovascular magnetic resonance imaging
determined that LV volume, mass and linear dimensions in
a normal adult population free of clinically overt cardiovas-
cular disease are affected by gender and body size. Left
ventricular EDV, ESV and mass are all greater in men than
in women, regardless of adjustment for height or BSA. This
study provides gender-specific CMR reference values for a
clinically relevant population in whom cardiovascular dis-
ease and hypertension were rigorously excluded, and may
serve as normative reference data for this population.
Reprint requests and correspondence: Dr. Warren J. Manning,
Beth Israel Deaconess Medical Center, 330 Brookline Avenue,
Boston, Massachusetts 02215. E-mail: wmanning@caregroup.
harvard.edu.
REFERENCES
1. Ghali JK, Liao Y, Simmons B, et al. The prognostic role of left
ventricular hypertrophy in patients with or without coronary artery
disease. Ann Intern Med 1992;117:831–6.
2. Koren MJ, Devereux RB, Casale PN, et al. Relation of left ventricular
mass and geometry to morbidity and mortality in uncomplicated
essential hypertension. Ann Intern Med 1991;114:345–52.
3. Levy D, Garrison RJ, Savage DD, et al. Prognostic implications of
echocardiographically determined left ventricular mass in the Fra-
mingham Heart Study. N Engl J Med 1990;322:1561–6.
4. White HD, Norris RM, Brown MA, et al. Left ventricular end-
systolic volume as the major determinant of survival after recovery from
myocardial infarction. Circulation 1987;76:44–51.
5. Sakuma H, Fujita N, Foo TK, et al. Evaluation of left ventricular
volume and mass with breath-hold cine MR imaging. Radiology
1993;188:377–80.
6. Bellenger NG, Burgess MI, Ray SG, et al. Comparison of left
ventricular ejection fraction and volumes in heart failure by echocar-
diography, radionuclide ventriculography and cardiovascular magnetic
resonance; are they interchangeable? Eur Heart J 2000;21:1387–96.
7. Bottini PB, Carr AA, Prisant LM, et al. Magnetic resonance imaging
to assess left ventricular mass in the hypertensive patient. Am J
Hypertens 1995;8:221–8.
8. Lorenz CH, Walker ES, Morgan VL, et al. Normal human right and
left ventricular mass, systolic function, and gender differences by cine
magnetic resonance imaging. J Cardiovasc Magn Reson 1999;1:7–21.
9. Marcus JT, DeWaal LK, Gotte MJW, et al. MRI-derived left
ventricular function parameters and mass in healthy young adults:
relation with gender and body size. Int J Card Imaging 1999;15:411–9.
10. Gardin JM, Siscovick D, Anton-Culver H, et al. Sex, age and disease
affect echocardiographic left ventricular mass and systolic function in
the free-living elderly. The Cardiovascular Health Study. Circulation
1995;91:1739–48.
11. Kitzman DW, Scholz DG, Hagen PT, et al. Age-related changes in
normal human hearts during the first 10 decades of life. Part II
(Maturity): A quantitative anatomic study of 765 specimens from
subjects 20 to 99 years old. Mayo Clin Proc 1988;63:137–46.
12. Kannel WB, Feinleib M, McNamara PM, et al. An investigation of
coronary heart disease in families. The Framingham Offspring Study.
Am J Epidemiol 1979;110:281–90.
13. Wilson PW, D’Agostino RB, Levy D, et al. Prediction of coronary
heart disease using risk factor categories. Circulation 1998;97:1837–
47.
14. Sixth report of the Joint National Committee on Prevention, Detec-
tion, Evaluation and Treatment of High Blood Pressure (JNC VI).
Arch Intern Med 1997;158:2413–46.
15. Epstein FH, Wolff SD, Arai AE. Segmented k-space fast cardiac
imaging using an echo-train readout. Magn Reson Med 1999;41:609–
13.
16. Chuang ML, Hibberd MG, Salton CJ, et al. Importance of imaging
method over imaging modality in noninvasive determination of left
ventricular volumes and ejection fraction: assessment by two- and
three-dimensional echocardiography and magnetic resonance imaging.
J Am Coll Cardiol 2000;35:477–84.
17. Dubois D, Dubois EF. A formula to estimate the approximate surface
if height and weight are known. Arch Intern Med 1916;17:863–71.
18. Savage DD, Levy D, Dannenberg AL, et al. Association of echocar-
diographic left ventricular mass with body size, blood pressure and
physical activity (The Framingham Study). Am J Cardiol 1990;65:
371–6.
19. Devereux RB, Lutas EM, Casale PN, et al. Standardization of
M-mode echocardiographic left ventricular anatomic measurements.
J Am Coll Cardiol 1984;4:1222–30.
20. Bella JN, Devereux RB, Roman MJ, et al. Relations of left ventricular
mass to fat-free and adipose body mass: the strong heart study. The
Strong Heart Study Investigators. Circulation 1998;98:2538–44.
21. Gottdiener JS, Reda DJ, Materson BJ, et al. Importance of obesity,
race and age to the cardiac structural and functional effects of
hypertension. J Am Coll Cardiol 1994;24:1492–8.
22. Lauer MS, Anderson KM, Larson MG, et al. A new method for
indexing left venricular mass for differences in body size. Am J Cardiol
1994;74:487–91.
23. Lauer MS, Larson MG, Levy D. Gender-specific reference M-mode
values in adults: population-derived values with consideration of the
impact of height. J Am Coll Cardiol 1995;26:1039–46.
24. Levy D, Savage DD, Garrison RJ, et al. Echocardiographic criteria for
left ventricular hypertrophy: the Framingham Heart Study. Am J
Cardiol 1987;59:956–60.
25. Shub C, Klein AL, Zachariah PK, et al. Determination of left
ventricular mass by echocardiography in a normal population: effect of
age and sex in addition to body size. Mayo Clin Proc 1994;69:205–11.
26. Gopal AS, Schnellbaecher MJ, Shen Z, et al. Freehand three-
dimensional echocardiography for measurement of left ventricular
mass: in vivo anatomic validation using explanted human hearts. J Am
Coll Cardiol 1997;30:802–10.
27. Bellenger NG, Davies LC, Francis JM, et al. Reduction in sample size
for studies of remodeling in heart failure by the use of cardiovascular
magnetic resonance. J Cardiovasc Magn Reson 2000;2:271–8.
28. Hundley WG, Hamilton CA, Thomas MS, et al. Utility of fast cine
magnetic resonance imaging and display for the detection of myocar-
dial ischemia in patients not well suited for second harmonic stress
echocardiography. Circulation 1999;100:1697–1702.
29. Yang PC, Kerr AB, Liu AC, et al. New real-time interactive cardiac
magnetic resonance imaging system complements echocardiography.
J Am Coll Cardiol 1998;32:2049–56.
30. Setser RM, Fischer SE, Lorenz CH. Quantification of left ventricular
function with magnetic resonance images acquired in real time. J
Magn Reson Imaging 2000;12:430–8.
31. Whalley GA, Gamble GD, Doughty RN, et al. Selection bias in
clinical research when subjects are excluded because of failure to
estimate left ventricular mass by echocardiography. J Am Soc Echo-
cardiogr 1998;11:1050–5.
32. Pluim BM, Zwinderman AH, van der Laarse A, et al. The athlete’s
heart. A meta-analysis of cardiac structure and function. Circulation
2000;101:336–44.
1060 Salton et al. JACC Vol. 39, No. 6, 2002
Gender Differences in Normal LV Anatomy by Cardiac MR March 20, 2002:1055–60
